2276-90-6CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1IUXIGWFXRQKWHHA-UHFFFAOYSA-NIotalamic acid is an organic molecular entity.
2276-90-6DTXSID5023164CHEMBL1201300CHEBI:31713Pharmaceuticals
Pharmaceuticals -> Listed in ZINC15
化学的特性Off-white Solid
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
70 [mg/m3]
770 [mg/m3]
4600 [mg/m3]
V - Various
QV - Various
16CHD79MIX
IOTHALAMIC ACID
Established Pharmacologic Class [EPC] - Radiographic Contrast Agent
Mechanisms of Action [MoA] - X-Ray Contrast Activity
Iothalamic acid is a Radiographic Contrast Agent. The mechanism of action of iothalamic acid is as a X-Ray Contrast Activity.
Renal accumulation is sufficiently rapid that maximum radiographic density in the calyces and pelves occurs, in most instances, about 3 to 8 minutes after injection. In patients with impaired renal function, diagnostic opacification frequently is achieved only after prolonged periods.
Following intravascular injection, Conray is rapidly transported through the circulatory system to the kidneys and is excreted unchanged in the urine by glomerular filtration. The liver and small intestine provide the major alternate route of excretion. In patients with severe renal impairment, the excretion of this contrast medium through the gallbladder and into the small intestine sharply increases.
現在のフィルター条件では反応記録がありません。
読み込み中…